IRINOTECAN HYDROCHLORIDE | N207793 | IPSEN BIOPHARMACEUTICALS INC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2025-00505 | 11344552 | IPR | CSPC Pharmaceutical Group Limited et al. | Trial Instituted | 2025-01-17 | 2025-08-14 |
| IPR2025-01531 | 11344552 | IPR | Apotex Inc. | Trial Instituted | 2025-09-12 | 2026-03-03 |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
IPSEN BIOPHARMACEUTICALS, INC. et al v. CONJUPRO BIOTHERAPEUTICS, INC. et al 1 patentirinotecan liposome injection | D.N.J. | 2025-07-22 | Terminated 2025-09-05 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8147867 | Aug 29, 2028 | — | Yes | Yes | — | — |
| 8329213 | Jan 6, 2027 | — | Yes | Yes | — | — |
| 9339497 | Jun 12, 2033 | — | — | — | — | |
| 9364473 | Jun 12, 2033 | — | — | — | — | |
| 9452162 | Jun 12, 2033 | — | — | — | — | |
| 9492442 | Jun 12, 2033 | — | — | — | — | |
| 9717724 | Jun 12, 2033 | — | — | — | — | |
| 10456360 | Oct 15, 2036 | — | — | Yes | — | — |
| 10980795 | Jun 12, 2033 | — | — | — | — | |
| 10993914 | Oct 15, 2036 | — | — | Yes | — | — |
| 11344552 | Aug 19, 2036 | — | — | — | — | |
| 11369597 | Jun 12, 2033 | — | — | — | — | |
| 12059497 | Oct 15, 2036 | — | — | Yes | — | — |
| 12364691 | Jun 12, 2033 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| I-932 | Feb 13, 2027 | < 1 year |
| ODE-463 | Feb 13, 2031 | Active |